enEvolv Acquired by Zymergen
Earlier today, we announced enEvolv’s acquisition by Zymergen. We are honored and excited to be a part of the Zymergen family, merging our ultra-high throughput microbial screening and engineering with Zymergen’s genome engineering, automation and machine learning capabilities. This is a great day for both organizations, and together, we will accelerate the discovery and delivery of new, high-value products to market. You can read more from Zymergen CEO Josh Hoffman.
This acquisition further unlocks the power of our platform, and enables us to push the discovery of new materials even further.
Colin, George & Jay